HLA-E and -G genes show a restricted polymorphism encoding for molecules wh
ose variability is limited at the peptide binding site. Fourteen alleles th
at give rise to only three productive proteins for HLA-G (*0101, *0103 and
*0104) and five alleles with three different proteins for HLA-E ("0101, *01
02 and *0103) have been described. Expression of these molecules is low and
found in many tissues for HLA-E; HLA-G protein is expressed in extravillou
s trophoblast cells and thymic epithelium. Molecular studies have shown how
HLA-G and HLA-E bind to natural killer (NK) cells immunoglobulin and lecti
n-type inhibitory receptors. HLA-E may act as a sentinel of the cell; if cl
assical class I and HLA-G are being expressed, HLA-E molecules may reach th
e cell surface and inhibit the lysis by NK cells. Most findings are consist
ent with the hypothesis that HLA-E and -G proteins may be tolerogenic molec
ules at either the T-cell receptor (TcR) (inflammation, graft rejection) or
NK level, switching off cells which usually attack foreign (including foet
us) or self (autoimmune) antigens. A lour HLA-E and -G polymorphism is obse
rved in humans, and their allele frequencies are mostly homogeneous in the
populations tested so far. Many studies to detect these alleles are now bei
ng performed in isolated populations and also in pregnancy-associated patho
logies. In the present paper, standard and detailed techniques to detect HL
A-E and -G DNA polymorphism are reported and discussed.